LeBlanc, E.S. http://orcid.org/0000-0002-4067-3432
Rosales, A.G.
Genant, H.K.
Dell, R.M.
Friess, D.M.
Boardman, D.L.
Santora, A.C.
Bauer, D.C.
de Papp, A.E.
Black, D.M.
Orwoll, E.S.
Funding for this research was provided by:
Merck
Article History
Received: 20 February 2018
Accepted: 21 January 2019
First Online: 26 February 2019
Compliance with ethical standards
:
: Erin LeBlanc’s and Ana G. Rosales’s institutions received a grant from Merck & Co., Inc. to conduct this work. Erin LeBlanc’s institution has also received grant funding from Amgen, Astra Zeneca, and Bristol Meyer Squibb for unrelated projects on which she was principal or co-investigator; however, these other projects do not reflect a conflict of interest. Arthur Santora was an employee of Merck during this work but has since retired; he currently has stocks, stock options, and pension from Merck. Anne de Papp is a current employee of Merck & Co., Inc. Harry Genant, Richard Dell, Darin Friess, David Boardman, Douglas Bauer, Anne de Papp, Dennis Black, and Eric Orwoll declare that they have no conflict of interest.